Antimicrobial susceptibilities of multidrug-resistant Campylobacter jejuni and C. coli strains: In vitro activities of 20 antimicrobial agents

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 3, 2010, Pages 1232-1236

  Lehtopolku, Mirva ^a,b   Nakari, Ulla Maija ^a   Kotilainen, Pirkko ^a,b   Huovinen, Pentti ^a   Siitonen, Anja ^a   Hakanen, Antti J ^a,b  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZITHROMYCIN; CARBAPENEM; CHLORAMPHENICOL; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; ERYTHROMYCIN; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MACROLIDE; MEROPENEM; MOXIFLOXACIN; NALIDIXIC ACID; NORFLOXACIN; OFLOXACIN; SITAFLOXACIN; TELITHROMYCIN; TETRACYCLINE; TIGECYCLINE;

AGAR DILUTION; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CAMPYLOBACTER COLI; CAMPYLOBACTER JEJUNI; CAMPYLOBACTERIOSIS; DISK DIFFUSION; EPSILOMETER TEST; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; SCREENING;

ANTI-BACTERIAL AGENTS; CAMPYLOBACTER COLI; CAMPYLOBACTER INFECTIONS; CAMPYLOBACTER JEJUNI; CARBAPENEMS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ERYTHROMYCIN; FECES; FINLAND; HUMANS; MACROLIDES; MICROBIAL SENSITIVITY TESTS; MINOCYCLINE;

EID: 77149132435     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00898-09     Document Type: Article

References (28)

1. Aarestrup, F. M., and J. Engberg. 2001. Antimicrobial resistance of thermophilic Campylobacter. Vet. Res. 32:311-321.
2. Agwuh, K. N., and A. MacGowan. 2006. Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines. J. Antimicrob. Chemother. 58:256-265.
3. Allos, B. M. 2001. Campylobacter jejuni infections: update on emerging issues and trends. Clin. Infect. Dis. 32:1201-1206.
4. Arai, A., A. Kitano, E. Sawabe, H. Kanegane, T. Miyawaki, and O. Miura. 2007. Relapsing Campylobacter coli bacteremia with reactive arthritis in a patient with X-linked agammaglobulinemia. Intern. Med. 46:605-609.
5. Belanger, A. E., and T. R. Shryock. 2007. Macrolide-resistant Campylobacter: the meat of the matter. J. Antimicrob. Chemother. 60:715-723.
6. Breedt, J., J. Teras, J. Gardovskis, F. J. Maritz, T. Vaasna, D. P. Ross, M. Gioud-Paquet, N. Dartois, E. J. Ellis-Grosse, and E. Loh. 2005. Safety and efficacy of tigecycline in treatment of skin and skin structure infections: results of a double-blind phase 3 comparison study with vancomycin-aztreonam. Antimicrob. Agents Chemother. 49:4658-4666.
7. CLSI. 2009. Performance standards for antimicrobial susceptibility testing, 19th informational supplement M100-S19. Clinical and Laboratory Standards Institute, Wayne, PA.
8. Engberg, J., F. M. Aarestrup, D. E. Taylor, P. Gerner-Smidt, and I. Nachamkin. 2001. Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: resistance mechanisms and trends in human isolates. Emerg. Infect. Dis. 7:24-34.
9. Engberg, J., J. Neimann, E. M. Nielsen, F. M. Aarestrup, and V. Fussing. 2004. Quinolone-resistant Campylobacter infections in Denmark: risk factors and clinical consequences. Emerg. Infect. Dis. 10:1056-1063.
10. Gaudreau, C., Y. Girouard, L. Ringuette, and C. Tsimiklis. 2007. Comparison of disk diffusion and agar dilution methods for erythromycin and ciprofloxacin susceptibility testing of Campylobacter jejuni subsp. jejuni. Antimicrob. Agents Chemother. 51:1524-1526.
11. Hakanen, A., H. Jousimies-Somer, A. Siitonen, P. Huovinen, and P. Kotilainen. 2003. Fluoroquinolone resistance in Campylobacter jejuni isolates in travelers returning to Finland: association of ciprofloxacin resistance to travel destination. Emerg. Infect. Dis. 9:267-270.
12. Hakanen, A. J., M. Lehtopolku, A. Siitonen, P. Huovinen, and P. Kotilainen. 2003. Multidrug resistance in Campylobacter jejuni strains collected from Finnish patients during 1995-2000. J. Antimicrob. Chemother. 52:1035-1039.
13. Helms, M., J. Simonsen, K. E. P. Olsen, and K. Mølbak. 2005. Adverse health events associated with antimicrobial drug resistance in Campylobacter species: a registry-based cohort study. J. Infect. Dis. 191:1050-1055.
14. Hoge, C. W., J. M. Gambel, A. Srijan, C. Pitarangsi, and P. Echeverria. 1998. Trends in antibiotic resistance among diarrheal pathogens isolated in Thailand over 15 years. Clin. Infect. Dis. 26:341-345.
15. Kerstens, P. J. S. M., H. P. Endtz, J. F. G. M. Meis, W. J. G. Oyen, R. J. I. Koopman, P. J. van den Broek, and J. W. M. van der Meer. 1992. Erysipelaslike skin lesions associated with Campylobacter jejuni septicemia in patients with hypogammaglobulinemia. Eur. J. Clin. Microbiol. Infect. Dis. 11:842-847.
16. Lau, S. K. P., P. C. Y. Woo, K. W. Leung, and K. Y. Yuen. 2002. Emergence of cotrimoxazole- and quinolone-resistant Campylobacter infections in bone marrow transplant recipients. Eur. J. Clin. Microbiol. Infect. Dis. 21:127-129.
17. Lehtopolku, M., A. J. Hakanen, A. Siitonen, P. Huovinen, and P. Kotilainen. 2005. In vitro activities of 11 fluoroquinolones against 226 Campylobacter jejuni strains isolated from Finnish patients, with special reference to cipro-floxacin resistance. J. Antimicrob. Chemother. 56:1134-1138.
18. Monselise, A., D. Blickstein, I. Ostfeld, R. Segal, and M. Weinberger. 2004. A case of cellulitis complicating Campylobacter jejuni subspecies jejuni bacteremia and review of the literature. Eur. J. Clin. Microbiol. Infect. Dis. 23:718-721.
19. Muralidharan, G., M. Micalizzi, J. Speth, D. Raible, and S. Troy. 2005. Pharmacokinetics of tigecycline after single and multiple doses in healthy subjects. Antimicrob. Agents Chemother. 49:220-229.
20. Nakari, U. M., A. Puhakka, and A. Siitonen. 2008. Correct identification and discrimination between Campylobacter jejuni and C. coli by a standardized hippurate test and species-specific polymerase chain reaction. Eur. J. Clin. Microbiol. Infect. Dis. 27:513-518.
21. Okada, H., T. Kitazawa, S. Harada, S. Itoyama, S. Hatakeyama, Y. Ota, and K. Koike. 2008. Combined treatment with oral kanamycin and parenteral antibiotics for a case of persistent bacteremia and intestinal carriage with Campylobacter coli. Intern. Med. 47:1363-1366.
22. Rodríguez-Avial, I., C. Rodríguez-Avial, O. López, E. Culebras, and J. J. Picazo. 2006. In vitro activity of tigecycline (GAR-936) and other antimicrobials against tetracycline- and ciprofloxacin-resistant Campylobacter clinical isolates. Int. J. Antimicrob. Agents 27:303-306.
23. Schönberg-Norio, D., M. L. Hänninen, M. L. Katila, S. S. Kaukoranta, M. Koskela, E. Eerola, J. Uksila, S. Pajarre, and H. Rautelin. 2006. Activities of telithromycin, erythromycin, fluoroquinolones, and doxycycline against Campylobacter strains isolated from Finish subjects. Antimicrob. Agents Chemother. 50:1086-1088.
24. Schönberg-Norio, D., L. Mattila, A. Lauhio, M. L. Katila, S. S. Kaukoranta, M. Koskela, S. Pajarre, J. Uksila, E. Eerola, S. Sarna, and H. Rautelin. 4 November 2009. Patient-reported complications associated with Campylobacter jejuni infection. Epidemiol. Infect. [Epub ahead of print.] doi: 10.1017/S0950268809991099.
25. Tajada, P., J. L. Gomez-Garces, J. I. Alós, D. Balas, and R. Cogollos. 1996. Antimicrobial susceptibilities of Campylobacter jejuni and Campylobacter coli to 12 β-lactam agents and combinations with β-lactamase inhibitors. Antimicrob. Agents. Chemother. 40:1924-1925.
26. Tam, C. C., L. C. Rodrigues, I. Petersen, A. Islam, A. Hayward, and S. J. O'Brien. 2006. Incidence of Guillan-Barré syndrome among patients with Campylobacter infection: a general practice research database study. J. Infect. Dis. 194:95-97.
27. Travers, K., and M. Barza. 2002. Morbidity of infections caused by antimicrobial-resistant bacteria. Clin. Infect. Dis. 34(Suppl. 3):S131-S134.
28. Vlieghe, E. R., J. A. Jacobs, M. Van Esbroeck, O. Koole, and A. Van Gompel. 2008. Trends of norfloxacin and erythromycin resistance of Campylobacter jejuni/Campylobacter coli isolates recovered from international travelers, 1994 to 2006. J. Travel Med. 15:419-425.